Swiss Biotech – Industry news, events, directory, Swiss Biotech Association

May 4-5, 2026

The power of international collaboration

Get the insight

Swiss Biotech Report 2025

In print & digitally

The leading compedium of Swiss Biotech

How did we fare in 2024?

Our association in facts and figures

Become a Member

Loads of reasons to join

Invest in Swiss biotechs

Discover investment and partnering opportunities

Talent meets opportunities

Become part of the thriving community

Create lasting business ties

Connect with the Swiss biotech ecosystem

Get the insight

Swiss Biotech Report 2025

Don’t fall for fraudsters! Cyber criminals can reach you easily with today's communication means. We regularly detect fraudulent emails attempting to steal your passwords — both personal and for our systems — through phishing attacks. Smishing (SMS, text messages) or vishing (phone calls) are also a common way to retrieve information from you. With seemingly legitimate messages the criminals
October 8, 2024

PSI CRO, a Swiss-based global full-service contract research organization (CRO), today announced the launch of SYNETIC, a next-generation AI-powered semantic knowledge platform that empowers sponsors to identify optimal trial sites, minimize startup delays, and predict and eliminate non-enrolling sites.
January 29, 2026

leadXpro AG (“leadXpro”), a Switzerland-based pharmaceutical research and development company, and Partex.AI (“Partex”), an AI-driven therapeutic asset incubator and accelerator, today announced that they have entered into a collaboration agreement focused on expanding the therapeutic potential and supporting the future out-licensing of LeadXpro’s adenosine A2B receptor (A2BR) antagonist
January 28, 2026

abc biopply ag and Pathways Preclinical Partners (“Path2P”) today announced a new collaboration aimed at enforcing the integration of abc biopply’s cutting-edge preclinical NAM technology 3D CoSeedis within global drug development networks in the US.
January 28, 2026